← back to search

Beatrice Uziely

Hadassah Medical Center · IL
Area of research
Cancer Research · Hematology
Research interest
Research interests include Breast Cancer Treatment Studies, Blood Coagulation and Thrombosis Mechanisms, Cancer Treatment and Pharmacology, and Cancer Genomics and Diagnostics.
h-index
31
citations
6,199
works
127
NIH funding
primary concept
Medicine
email

Recent publications

PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
Molecular Cancer Therapeutics 2022cited by 5position: middledoi
Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
Scientific Reports 2019cited by 5position: middledoi
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry
npj Breast Cancer 2017cited by 69position: middledoi
The oncology nurse coordinator: role perceptions of staff members and nurse coordinators
Israel Journal of Health Policy Research 2017cited by 19position: middledoi
Unemployment risk 2 years and 4 years following gastric cancer diagnosis: a population-based study
Journal of Cancer Survivorship 2016cited by 14position: middledoi
Is<sup>18</sup>F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?
Acta Oncologica 2015cited by 4position: middledoi
An observational cohort study of bevacizumab and chemotherapy in metastatic colorectal cancer patients: safety and efficacy with analysis by age group
Targeted Oncology 2014cited by 19position: lastdoi
Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer
Cellular and Molecular Life Sciences 2013cited by 36position: middledoi
Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer
Breast Cancer Research and Treatment 2013cited by 32position: middledoi
Hypertension as a predictive biomarker in bevacizumab treatment for colorectal cancer patients
Medical Oncology 2012cited by 44position: middledoi
Regulation of human protease‐activated receptor 1 ( <i>hPar1</i> ) gene expression in breast cancer by estrogen
The FASEB Journal 2012cited by 11position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tamar Peretz · Hebrew University of Jerusalem7 papers (2012–2019)Esther Tahover · Shaare Zedek Medical Center3 papers (2012–2015)Tamar Hamburger · Hebrew University of Jerusalem3 papers (2012–2014)Rachel Bar‐Shavit · Hadassah Medical Center3 papers (2012–2022)Azzam Salah · Hebrew University of Jerusalem3 papers (2012–2019)Miriam Maoz · Hebrew University of Jerusalem2 papers (2012–2013)Ayala Hubert · Hadassah Medical Center2 papers (2012–2014)Mohammad Jaber · Hebrew University of Jerusalem2 papers (2012–2013)Hovav Nechushtan · Hadassah Medical Center2 papers (2013–2019)Amir Sonnenblick · Ariel University2 papers (2013–2019)Luna Kadouri · Hebrew University of Jerusalem2 papers (2013–2019)Mark Temper · Hebrew University of Jerusalem2 papers (2012–2014) · 1 papers (2022–2022)Bella Maly · Hebrew University of Jerusalem1 papers (2012–2012)Aviad Zick · Hadassah Medical Center1 papers (2019–2019)Ella Evron · Hebrew University of Jerusalem1 papers (2017–2017)Bela Maly · Hebrew University of Jerusalem1 papers (2013–2013) · 1 papers (2022–2022)Amnon Hoffman · Hebrew University of Jerusalem1 papers (2022–2022) · 1 papers (2019–2019)